1. Home
  2. KOD vs SLRC Comparison

KOD vs SLRC Comparison

Compare KOD & SLRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOD
  • SLRC
  • Stock Information
  • Founded
  • KOD 2009
  • SLRC 2007
  • Country
  • KOD United States
  • SLRC United States
  • Employees
  • KOD N/A
  • SLRC N/A
  • Industry
  • KOD Biotechnology: Biological Products (No Diagnostic Substances)
  • SLRC Finance/Investors Services
  • Sector
  • KOD Health Care
  • SLRC Finance
  • Exchange
  • KOD Nasdaq
  • SLRC Nasdaq
  • Market Cap
  • KOD 795.5M
  • SLRC 889.2M
  • IPO Year
  • KOD 2018
  • SLRC 2010
  • Fundamental
  • Price
  • KOD $14.05
  • SLRC $14.69
  • Analyst Decision
  • KOD Buy
  • SLRC Hold
  • Analyst Count
  • KOD 6
  • SLRC 6
  • Target Price
  • KOD $14.33
  • SLRC $15.96
  • AVG Volume (30 Days)
  • KOD 1.0M
  • SLRC 254.8K
  • Earning Date
  • KOD 11-13-2025
  • SLRC 11-04-2025
  • Dividend Yield
  • KOD N/A
  • SLRC 11.25%
  • EPS Growth
  • KOD N/A
  • SLRC N/A
  • EPS
  • KOD N/A
  • SLRC 1.63
  • Revenue
  • KOD N/A
  • SLRC $222,445,000.00
  • Revenue This Year
  • KOD N/A
  • SLRC N/A
  • Revenue Next Year
  • KOD N/A
  • SLRC $0.23
  • P/E Ratio
  • KOD N/A
  • SLRC $8.96
  • Revenue Growth
  • KOD N/A
  • SLRC N/A
  • 52 Week Low
  • KOD $1.92
  • SLRC $13.64
  • 52 Week High
  • KOD $19.39
  • SLRC $17.94
  • Technical
  • Relative Strength Index (RSI)
  • KOD 56.85
  • SLRC 27.70
  • Support Level
  • KOD $13.91
  • SLRC $14.56
  • Resistance Level
  • KOD $17.12
  • SLRC $15.31
  • Average True Range (ATR)
  • KOD 2.04
  • SLRC 0.29
  • MACD
  • KOD -0.13
  • SLRC -0.09
  • Stochastic Oscillator
  • KOD 46.80
  • SLRC 11.21

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

About SLRC SLR Investment Corp.

SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. It invests majorly in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities.

Share on Social Networks: